SLC16A1 and cancer: Among them there are 2-deoxy glucose (hexokinase inhibitor, tested alone or in combination with docetaxel in patients with advanced solid tumors) [106], lonidamine (hexokinase inhibitor, tested in combination with various chemotherapeutic agents, e.g. 5-fluorouracil, doxorubicin, cisplatin in several advanced cancer) [107], indisulam (carbonic anhydrase inhibitor, tested in combination with capecitabine/Irinotecan in metastatic colorectal cancer) [108] and AZD3965 (MCT1 inhibitor, tested alone in some lymphomas and solid tumors) [104].